Article
Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
Scientific reports - 5 Oct 2023
Ferreira Ana Maria Castro, Altemani João Maurício Carrasco, Macedo Ligia Traldi, Lourenço Gustavo Jacob, Lima Carmen Silvia Passos
Abstract excerpt
Advanced head and neck squamous cell carcinoma (HNSCC) patients have been treated with cisplatin (CDDP) chemoradiation, and the variability of treatment effects has been attributed to single nucleotide variants (SNVs) in genes of metabolic pathways. This study investigated the roles of GSTM1, GSTT1, GSTP1 c.313A>G, XPC c.2815A>C, XPD c.934G>A and c.2251A>C, XPF c.2505T>C, ERCC1 c.354C>T, MLH1 c.93G>A, MSH2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
